Bob Burrows | Vice President of Investor Relations |
Dan Abdun Nabi | Chief Executive Officer |
Bob Kramer | President and Chief Operating Officer |
Rich Lindahl | Chief Financial Officer |
Doug White | Senior Vice President, Devices Business Unit Head |
Abigail Jenkin | Senior Vice President, Vaccines and Anti-infectives Business Unit Head |
Atul Saran | Executive Vice President, Corporate Development and General Counsel |
Brandon Folkes | Cantor Fitzgerald |
Dana Flanders | Goldman Sachs |
Boris Peaker | Cowen and Company |
Keay Nakae | Chardan |
Jessica Fye | J.P. Morgan |
David Maris | Wells Fargo |
Lisa Springer | Singular Research |
Good day, ladies and gentlemen. And welcome to Emergent BioSolutions Inc.
Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time [Operator Instructions].